Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Operating Expenses | 13,269 | 7,979 | 6,580 | 16,131 | 10,306 |
| Operating Income | -13,269 | -7,979 | -6,580 | -16,131 | -10,306 |
| Other Income | -5,252 | -1,521 | 353 | 4,786 | -3,716 |
| Pre-tax Income | -18,522 | -9,499 | -6,227 | -11,345 | -14,022 |
| Net Income Continuous | -18,522 | -9,499 | -6,227 | -11,345 | -14,022 |
| Net Income | $-18,522 | $-9,499 | $-6,227 | $-11,345 | $-14,022 |
| EPS Basic Total Ops | -52.82 | -33.61 | -28.81 | -57.62 | -86.43 |
| EPS Basic Continuous Ops | -50.50 | -35.46 | -30.78 | -58.55 | -85.60 |
| EPS Diluted Total Ops | -52.82 | -33.61 | -28.81 | -57.62 | -86.43 |
| EPS Diluted Continuous Ops | -50.50 | -35.46 | -30.78 | -58.55 | -85.60 |
| EBITDA(a) | $-13,477 | $-8,750 | $-6,682 | $-16,181 | $-10,350 |